RIG-I signaling can also trigger the activation of DCs, NK cells, and subsequent CD8+ T cells to induce immunogenic death of cancer cells (Kübler et al., 2010; Ellermeier et al., 2013; Duewell et al., 2014). This evidence concerns the gene CD8A and cancer.